NIVAS News Hub

Do you have news you would like to share on the NIVAS News Hub?

If you have an RSS feed you wish to share with up please contact us here.

Showing 133-144 of 800 results.

IVTEAM

Prevention of CRBSI in United States hemodialysis facilities

"New commercially available products containing chlorhexidine and taurolidine promise to augment core interventions to prevent CRBSI in dialysis facilities. This manuscript reviews selected topics and recent advances in knowledge related to preventing CRBSI in HD, with emphasis on dialysis care in United States" Wong (2025).

IVTEAM

Review of non-tunneled hemodialysis catheters

"Triple-lumen catheters were associated with a higher risk of infection, but their increasing use over time coincided with a decline in infection rates. Further research is needed to confirm these findings and explore the mechanisms underlying demographic and design-related infection risks" Miller et al (2025).

IVTEAM

Neonatal PICC subspecialty in neonatal vascular access – Full Text

"This perspective review examines the evolving role of neonatal peripherally inserted central catheters (n-PICCs) as a distinct subspecialty within neonatal vascular access. n-PICCs are indispensable for delivering long-term intravenous therapies in critically ill neonates" Van Rens et al (2025).

IVTEAM

Incidence of phlebitis caused by continuous cephalosporin IV infusion – Full Text

"Phlebitis was more severe in the cephalothin group and developed more rapidly, necessitating vein changes six times more often than in the cephapirin group. The less irritating properties of cephapirin demonstrated in this study indicate it may be the more useful cephalosporin analogue for intravenous therapy" Lane et al (2025).

IVTEAM

OPAT hospital readmission risk factors – Full Text

"he identification of characteristics of patients who return to the hospital after being discharged on OPAT may identify modifiable steps that can be taken to reduce risk of hospital readmission as a practice improvement strategy" Yousif et al (2025).

IVTEAM

Extravasation of radiopharmaceuticals research study

"[177Lu]Lu-DOTATATE was administered intravenously to outpatients following standard peptide receptor radionuclide therapy protocols. Whole-body planar imaging was performed 3-4 h after injection to confirm administration and assess extravasation, indicated by focal increased uptake at the infusion site" Kayal et al (2025).

NIVAS Partners

The NIVAS Board

UK Vessel Health & Preservation Video